Cassava Sciences
SAVA
#9211
Rank
A$0.16 B
Marketcap
A$3.44
Share price
12.26%
Change (1 day)
44.11%
Change (1 year)

Earnings for Cassava Sciences (SAVA)

Earnings in 2025 (TTM): -A$0.18 Billion

According to Cassava Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$0.21 Billion a decrease over its 2023 earnings that were of -A$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cassava Sciences from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.18 Billion-14.79%
2024 -A$0.21 Billion34.28%
2023 -A$0.16 Billion32.41%
2022 -A$0.12 Billion143.46%
2021 -A$47.47 Million383.92%
2020 -A$9.81 Million36.96%
2019 -A$7.17 Million-25.56%
2018 -A$9.63 Million-44.25%
2017 -A$17.26 Million-20.11%
2016 -A$21.6 Million5.32%
2015 -A$20.51 Million14.23%
2014 -A$17.96 Million-139.64%
2013 A$45.29 M
2010 -A$19.79 Million102.87%
2009 -A$9.76 Million-177.52%
2008 A$12.58 M-14.32%
2007 A$14.68 M-1942.21%
2006 -A$0.8 Million
2004 -A$56.27 Million75.1%
2003 -A$32.14 Million
2001 -A$25.01 Million20.49%
2000 -A$20.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.22 Billion 31.98%๐Ÿ‡บ๐Ÿ‡ธ USA